Literature DB >> 15158347

Interferon-alpha for hepatitis C: antiviral or immunotherapy?

Helmut M Diepolder.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15158347     DOI： 10.1016/j.jhep.2004.04.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.

Authors:  Julian Schulze Zur Wiesch; Georg M Lauer; Joerg Timm; Thomas Kuntzen; Martin Neukamm; Andrew Berical; Andrea M Jones; Brian E Nolan; Steve A Longworth; Victoria Kasprowicz; Cory McMahon; Alysse Wurcel; Ansgar W Lohse; Lia L Lewis-Ximenez; Raymond T Chung; Arthur Y Kim; Todd M Allen; Bruce D Walker
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

2.  HCV genotype-3a T cell immunity: specificity, function and impact of therapy.

Authors:  Isla S Humphreys; Annette von Delft; Anthony Brown; Linda Hibbert; Jane D Collier; Graham R Foster; Monira Rahman; Annabel Christian; Paul Klenerman; Eleanor Barnes
Journal:  Gut       Date:  2012-02-15       Impact factor: 23.059

3.  Diverse Immunomodulatory Effects of Individual IFNα Subtypes on Virus-Specific CD8+ T Cell Responses.

Authors:  Julia Dickow; Sandra Francois; Rouven-Luca Kaiserling; Anna Malyshkina; Ingo Drexler; Astrid Maria Westendorf; Karl Sebastian Lang; Mario L Santiago; Ulf Dittmer; Kathrin Sutter
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.